Cullinan Associates Inc Gsk PLC Transaction History

Cullinan Associates Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 07, 2021	SELL	$36.52 - $41.46 $288,508 - $327,534	-7,900 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$34.27 - $40.01 $6,854 - $8,002	200 Added 2.6%	7,900 $282,000
Q4 2020 Jan 14, 2021	BUY	$34.07 - $39.94 $3,407 - $3,994	100 Added 1.32%	7,700 $283,000
Q3 2020 Oct 09, 2020	BUY	$38.11 - $42.99 $11,433 - $12,897	300 Added 4.11%	7,600 $286,000
Q2 2020 Jul 07, 2020	SELL	$37.87 - $43.58 $30,295 - $34,864	-800 Reduced 9.88%	7,300 $298,000
Q1 2020 Apr 01, 2020	SELL	$32.47 - $48.83 $616,930 - $927,770	-19,000 Reduced 70.11%	8,100 $307,000
Q4 2019 Jan 15, 2020	SELL	$42.0 - $48.25 $37,800 - $43,425	-900 Reduced 3.21%	27,100 $1.27 Million
Q3 2019 Oct 01, 2019	BUY	$40.46 - $43.52 $32,368 - $34,816	800 Added 2.94%	28,000 $1.2 Million
Q2 2019 Jul 16, 2019	SELL	$39.4 - $42.7 $78,800 - $85,400	-2,000 Reduced 6.85%	27,200 $1.09 Million
Q1 2019 Apr 30, 2019	SELL	$38.57 - $42.69 $11,571 - $12,807	-300 Reduced 1.02%	29,200 $1.22 Million
Q4 2018 Jan 11, 2019	BUY	$37.8 - $42.69 $238,139 - $268,947	6,300 Added 27.16%	29,500 $1.13 Million
Q3 2018 Oct 19, 2018	SELL	$39.75 - $42.69 $35,775 - $38,421	-900 Reduced 3.73%	23,200 $932,000
Q2 2018 Jul 09, 2018	SELL	$39.61 - $42.76 $83,181 - $89,796	-2,100 Reduced 8.02%	24,100 $971,000
Q1 2018 Apr 27, 2018	SELL	$36.18 - $40.15 $3,618 - $4,015	-100 Reduced 0.38%	26,200 $1.02 Million
Q4 2017 Jan 17, 2018	BUY	$35.34 - $41.9 $395,808 - $469,280	11,200 Added 74.17%	26,300 $933,000
Q3 2017 Oct 16, 2017	BUY	$39.44 - $41.55 $595,544 - $627,405	15,100	15,100 $613,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $71.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Cullinan Associates Inc with notifications on news.